Life Science Investing Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes 22 December
Life Science Investing Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans 19 December